| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC28651 | m-PEG4-Ms | m-PEG4-Ms is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28652 | Azido-PEG6-NHS ester | Azido-PEG6-NHS ester is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG6-NHS ester is also a PEG- and Alkyl/ether based PROTAC linker that can be used in the synthesis of PROTACs. |
|
| DC28653 | Azido-PEG9-acid | Azido-PEG9-acid is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28655 | N-Boc-PEG2-bromide | N-Boc-PEG2-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28656 | N-Boc-PEG7-alcohol | N-Boc-PEG7-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28663 | m-PEG7-Ms | m-PEG7-Ms is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28665 | Hydroxy-PEG3-SS-PEG3-alcohol | Hydroxy-PEG3-SS-PEG3-alcohol is also a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28666 | m-PEG9-Amine | m-PEG9-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28667 | Azido-PEG5-acid | Azido-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs), such as the conjugate CPT-APO (CPT: Camptothecin). |
|
| DC28668 | Propargyl-PEG4-Br | Propargyl-PEG4-Br is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28685 | Thalidomide-NH-PEG7 | Thalidomide-NH-PEG7 is a synthesized E3 ligase ligand-linker conjugate for ADC. Thalidomide-NH-PEG7 can be connected to the ligand for protein by a linker to form PROTAC iRucaparib-AP6, a highly specific PARP1 degrader. |
|
| DC28698 | DBCO-Sulfo-Link-biotin | DBCO-Sulfo-Link-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28699 | Gemcitabine-O-Si(di-iso)-O-Mc | Gemcitabine-O-Si(di-iso)-O-Mc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28719 | Fmoc-NH-PEG5-CH2COOH | Fmoc-NH-PEG5-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28720 | Fmoc-NH-PEG8-CH2COOH | Fmoc-NH-PEG8-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28766 | DC10SMe | DC10SMe is a DNA alkylator, can be used in the synthesis of Antibody-drug Conjugate (ADC). DC10SMe exhibits IC50s of 15 pM, 12 pM, and 12 pM for Ramos, Namalwa, and HL60/s cancer cells, respectively. |
|
| DC28767 | DC4SMe | DC4SMe, a phosphate prodrug of cytotoxic DNA alkylator DC4, can be used in the synthesis of Antibody-drug Conjugate (ADC). DC4SMe exhibits IC50s of 1.9 nM, 2.9 nM, and 1.8 nM for Ramos, Namalwa, and HL60/s cancer cells, respectively. DC4SMe can be used for the targeted treatment of cancer. |
|
| DC28768 | DC44SMe | DC44SMe, a phosphate prodrug of cytotoxic DNA alkylator DC44, can be used in the synthesis of Antibody-drug Conjugate (ADC). DC44SMe exhibits IC50s of 2.0 nM, 2.8 nM, and 1.9 nM for Ramos, Namalwa, and HL60/s cancer cells, respectively. DC44SMe can be used for the targeted treatment of cancer. |
|
| DC28769 | DC4 | DC4, a ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). DC4 can be used for the targeted treatment of cancer. |
|
| DC28770 | DC44 | DC44, a ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). DC44 can be used for the targeted treatment of cancer. |
|
| DC28861 | Fmoc-Asp-NH2 | Fmoc-Asp-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC28907 | MMAE-SMCC | MMAE-SMCC is a drug-linker conjugate for ADC. MMAE-SMCC is composed of a potent mitotic and a tubulin inhibitor MMAE and a linker SMCC to make antibody drug conjugate. |
|
| DC29011 | NH-bis(C1-Boc) | NH-bis(C1-Boc)is a uncleavable linker used for antibody-drug conjugates (ADC). |
|
| DC29012 | Mal-amido-(CH2COOH)2 | Mal-amido-(CH2COOH)2, compound 7a, is a maleimidoethyl-containing intermediate for hydrophilic ADC linker. |
|
| DC29013 | Tetraethylene glycol monotosylate Featured | Tetraethylene glycol monotosylate is a cleavable and acylhydrazone-based ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
.gif)
|
| DC29014 | Mal-L-PA-NH-Boc | Mal-L-PA-NH-Boc is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC29015 | BMPS | BMPS is a nonclaevable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
|
| DC29017 | Hydroxy-PEG3-(CH2)2-Boc | Hydroxy-PEG2-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG2-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 196). |
|
| DC29018 | N3-PEG3-CH2CH2-Boc | N3-PEG3-CH2CH2-Boc is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-CH2CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs. |
|
| DC29020 | Azido-PEG4-CH2-Boc | Azido-PEG4-CH2-Boc is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG4-CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs. |
|
